Seeking Alpha

  Progenics Pharmaceuticals Inc. (PGNX) - NASDAQ

  • Harvard Business Case - $PGNX | Send Message 9 Aug 2013

    How do they do it? ~10 lawyers, >50% Director Above, % of IT to employee way over. Is this company all smoke and mirrors? Who works? $PGNX
      PGNX vs. ETF Alternatives
      Company Description
      Progenics Pharmaceuticals Inc is engaged in the development of medicines for oncology .It develops products for the treatment of prostate cancer, for the treatment of opioid-induced constipation, or OIC, as well as OIC for non-cancer pain.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States